There are 2 papers on development of Alzheimer's disease in aging research: 1 observational study in people, 1 review.
2 papers study it198 more mention it4 findings
3 new papers in 30 daysSee all 200 papers on development of Alzheimer's disease
“their longitudinal changes were significantly associated with the development of Alzheimer's disease compared to controls over the 10-year follow-up”
- Humans1
Interventions
1Nonsteroidal anti-inflammatory drugs
no changein humans1HR 1.2
1 study
Nonsteroidal anti-inflammatory drugs
no changein humans1HR 1.2
Nonsteroidal anti-inflammatory drugs showed no clear effect on development of Alzheimer's disease in humans (People without Alzheimer's disease at baseline) (HR 1.20, 95% CI 0.95–1.51; P = 0.15).
“They also have no protective effect against the development of AD on their sustained use.”
ReviewPeople without Alzheimer's disease at baseline
Neurology India
Associations
3IL-6
mixedin humans1
1 study
IL-6
mixedin humans1
IL-6 is associated with development of Alzheimer's disease in humans (preclinical Alzheimer's disease participants versus controls).
“their longitudinal changes were significantly associated with the development of Alzheimer's disease compared to controls over the 10-year follow-up”
Humanspreclinical Alzheimer's disease participants versus controls10-year follow-upn = 290
Systemic inflammatory markers in ageing, Alzheimer's disease and other dementias
Brain : a journal of neurology
Interleukin-1β
mixedin humans1
1 study
Interleukin-1β
mixedin humans1
Interleukin-1β is associated with development of Alzheimer's disease in humans (preclinical Alzheimer's disease participants versus controls).
“their longitudinal changes were significantly associated with the development of Alzheimer's disease compared to controls over the 10-year follow-up”
Humanspreclinical Alzheimer's disease participants versus controls10-year follow-upn = 290
Systemic inflammatory markers in ageing, Alzheimer's disease and other dementias
Brain : a journal of neurology
Complement C3
mixedin humans1
1 study
Complement C3
mixedin humans1
Complement C3 is associated with development of Alzheimer's disease in humans (preclinical Alzheimer's disease participants versus controls).
“their longitudinal changes were significantly associated with the development of Alzheimer's disease compared to controls over the 10-year follow-up”
Humanspreclinical Alzheimer's disease participants versus controls10-year follow-upn = 290
Systemic inflammatory markers in ageing, Alzheimer's disease and other dementias
Brain : a journal of neurology